Compass Bioinformatics
Compass Bioinformatics offers InheriNext®, a Software as a Medical Device (SaMD) platform designed for next-generation sequencing (NGS) data interpretation and discovery in inherited diseases. Leveraging advanced AI and a variant ranking algorithm, InheriNext® empowers scientists and clinicians in hospitals and research laboratories to accelerate discovery and diagnosis. The platform automates routine tasks, ensures consistency with baked-in professional guidelines, and offers transparency into algorithm outputs. Key modules include Workflow Runner for FASTQ to VCF conversion, Phenotype Gene Prioritizer for variant ranking based on phenotypes and ACMG guidelines, PhenoVarDB for cohort analysis, and Expert for conversational AI-driven interpretation. The company has helped over 3500 patients since 2019, with physicians from 23 leading medical centers in Taiwan relying on their technology.
Compass Bioinformatics
Compass Bioinformatics offers InheriNext®, a Software as a Medical Device (SaMD) platform designed for next-generation sequencing (NGS) data interpretation and discovery in inherited diseases. Leveraging advanced AI and a variant ranking algorithm, InheriNext® empowers scientists and clinicians in hospitals and research laboratories to accelerate discovery and diagnosis. The platform automates routine tasks, ensures consistency with baked-in professional guidelines, and offers transparency into algorithm outputs. Key modules include Workflow Runner for FASTQ to VCF conversion, Phenotype Gene Prioritizer for variant ranking based on phenotypes and ACMG guidelines, PhenoVarDB for cohort analysis, and Expert for conversational AI-driven interpretation. The company has helped over 3500 patients since 2019, with physicians from 23 leading medical centers in Taiwan relying on their technology.